Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Atezolizumab in Combination With Entinostat and Bevacizumab in Patients With Advanced Renal Cell Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03024437
Recruitment Status : Recruiting
First Posted : January 18, 2017
Last Update Posted : February 20, 2019
Sponsor:
Collaborators:
Genentech, Inc.
Syndax Pharmaceuticals
Information provided by (Responsible Party):
Roberto Pili, Indiana University School of Medicine

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : January 31, 2020
Estimated Study Completion Date : January 31, 2021